Similar articles for PMID: 29301928

Year	Number of Results
2004	1
2005	1
2011	2
2015	3
2016	10
2017	14
2018	23
2019	24
2020	19
2021	21
2022	10
2023	5
2024	0

1

The Utility of PET/CT in the Planning of External Radiation Therapy for Prostate Cancer.

Calais J, Cao M, Nickols NG. Calais J, et al. J Nucl Med. 2018 Apr;59(4):557-567. doi: 10.2967/jnumed.117.196444. Epub 2018 Jan 4. J Nucl Med. 2018. PMID: 29301928 Free PMC article.

2

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

3

⁶⁸Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

Calais J, Czernin J, Cao M, Kishan AU, Hegde JV, Shaverdian N, Sandler K, Chu FI, King CR, Steinberg ML, Rauscher I, Schmidt-Hegemann NS, Poeppel T, Hetkamp P, Ceci F, Herrmann K, Fendler WP, Eiber M, Nickols NG. Calais J, et al. J Nucl Med. 2018 Feb;59(2):230-237. doi: 10.2967/jnumed.117.201749. Epub 2017 Nov 9. J Nucl Med. 2018. PMID: 29123013 Free PMC article.

4

Potential Impact of ⁶⁸Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.

Calais J, Kishan AU, Cao M, Fendler WP, Eiber M, Herrmann K, Ceci F, Reiter RE, Rettig MB, Hegde JV, Shaverdian N, King CR, Steinberg ML, Czernin J, Nickols NG. Calais J, et al. J Nucl Med. 2018 Nov;59(11):1714-1721. doi: 10.2967/jnumed.118.209387. Epub 2018 Apr 13. J Nucl Med. 2018. PMID: 29653978 Free PMC article. Clinical Trial.

5

The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment.

Mena E, Lindenberg L, Choyke P. Mena E, et al. Semin Nucl Med. 2022 Mar;52(2):255-262. doi: 10.1053/j.semnuclmed.2021.12.008. Epub 2022 Jan 10. Semin Nucl Med. 2022. PMID: 35016755 Free PMC article. Review.

6

Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review.

Valle L, Shabsovich D, de Meerleer G, Maurer T, Murphy DG, Nickols NG, Vapiwala N, Calais J, Kishan AU. Valle L, et al. Eur Urol Oncol. 2021 Jun;4(3):339-355. doi: 10.1016/j.euo.2021.01.007. Epub 2021 Feb 24. Eur Urol Oncol. 2021. PMID: 33637464 Review.

7

Intention-to-Treat Analysis of ⁶⁸Ga-PSMA and ¹¹C-Choline PET/CT Versus CT for Prostate Cancer Recurrence After Surgery.

Schwenck J, Olthof SC, Pfannenberg C, Reischl G, Wegener D, Marzec J, Bedke J, Stenzl A, Nikolaou K, la Fougère C, Zips D, Müller AC. Schwenck J, et al. J Nucl Med. 2019 Oct;60(10):1359-1365. doi: 10.2967/jnumed.118.224543. Epub 2019 Mar 8. J Nucl Med. 2019. PMID: 30850491 Free article.

8

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy.

Schmidt-Hegemann NS, Fendler WP, Ilhan H, Herlemann A, Buchner A, Stief C, Eze C, Rogowski P, Li M, Bartenstein P, Ganswindt U, Belka C. Schmidt-Hegemann NS, et al. Radiat Oncol. 2018 Mar 2;13(1):37. doi: 10.1186/s13014-018-0983-4. Radiat Oncol. 2018. PMID: 29499730 Free PMC article.

9

¹⁸F-fluciclovine PET-CT and ⁶⁸Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.

Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J. Calais J, et al. Lancet Oncol. 2019 Sep;20(9):1286-1294. doi: 10.1016/S1470-2045(19)30415-2. Epub 2019 Jul 30. Lancet Oncol. 2019. PMID: 31375469 Free PMC article. Clinical Trial.

10

Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients.

Onal C, Torun N, Akyol F, Guler OC, Hurmuz P, Yildirim BA, Cağlar M, Reyhan M, Ozyigit G. Onal C, et al. Clin Nucl Med. 2019 Sep;44(9):e510-e516. doi: 10.1097/RLU.0000000000002691. Clin Nucl Med. 2019. PMID: 31283600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year